Business
CBD Life Sciences Subsidiary Launching Production for CBD Vaping Market
CBD Life Sciences Subsidiary Launching Production for CBD Vaping Market.
About this update from Cbd Life Sciences Inc.
[{"type":"text","content":"\nSCOTTSDALE, AZ, June 11, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE – CBD Life Sciences Inc. (OTC: CBDL) is pleased to announce that its wholly owned subsidiary, LBC Bioscience, has completed the development of a disposable CBD vape-pen. The product is now undergoing final market testing and is expected to be available for purchase within the next three to four weeks. \n\n \n \n \n \n \n \n \n \n \n \n \n LBC Bioscience CBD Vape Pen\n \n \n \n \n \n \n \n \n\n The CBD oil market is currently estimated to be $1.5 billion and some industry experts project it to grow to over $16 billion by 2025. Combine that with the e-cigarette vaping sector which is currently estimated to be $10 billion and projected to grow to $47 billion over the same period. With the development of this product LBC Bioscience is positioning itself to be a leader in the specialized CBD + e-cigarette vaping market. Initial responses from the market testing have exceeded expectations and pre-orders are already coming in for the product.   “The market for an application like this is immeasurable,” stated Lisa Nelson, President & CEO of CBD Life Science. “Combine the CBD phenonium with the current vaping trend and you have a no brainer. The feedback from our initial market testing was phenomenal resulting in pre-orders already coming in. This product is going to be a best seller…without a doubt,” continued Ms. Nelson. About CBD Life Sciences Inc. CBD Life Sciences Inc. is a publicly traded company having its common shares quoted on the OTC Markets under the symbol “CBDL”. The Company’s main focus is to identify, evaluate and acquire undervalued opportunities with the objective of increasing shareholder value. The acquisition of LBC Bioscience Inc. is the first in the CBD space and the company is actively searching for additional opportunities within this emerging sector. About LBC Bioscience Inc.   LBC Bioscience Inc. is a wholly owned subsidiary of CBD Life Sciences Inc. LBC has developed and is retailing/wholesaling a full line of cannabidiol based organic products including: hemp drops, massage oils, pain relief creams, anxiety and sleep  supplements, CDB edibles, anti-aging skin solutions and a full line of CBD infused supplements for your pets. LBC’s products can be viewed and purc...